scout

Authors

Gregory J. Riely, MD PhD, Memorial Sloan Kettering Cancer Center
Gregory J. Riely, MD, PhD, Weill Cornell Medical College
Gregory L. Beatty, MD, PhD
Latest Article

Dr. Beatty on the Potential for Immunotherapy in GI Malignancies

Gregory L. Beatty, MD, PhD, assistant professor of medicine, director of Tanslation Research, Pancreatic Cancer Research Center, University of Pennsylvania Perelman School of Medicine, discusses the potential for immunotherapy in gastrointestinal malignancies.

Gregory M. Springett, MD, PhD
Latest Article

Immunotherapy Combined With Chemotherapy for Pancreatic Cancer: A Game Changer?

This article reviews up-to-date clinical studies combining chemotherapy with immunotherapy; it also explains the rationale for this combination in treatment of pancreatic cancer.

Gregory Springett MD PhD
Latest Article

Phase II Clinical Trial of Intratumoral Dendritic Cells Injections and Neoadjuvant Radiotherapy in Resectable Soft Tissue Sarcomas

Neoadjuvant radiation with dendritic cell injections has the potential to be safe, effective, and immunogenic in high-grade soft tissue sarcoma and needs to be confirmed in randomized larger clinical trials.

Gustavo Fernandez, MD
Latest Article

Radiation for Chemo-Sensitization: A Phase II Trial of Cetuximab and Docetaxel With Low-Dose Fractionated Radiation for Recurrent Unresectable Locally Advanced Head and Neck Carcinoma

This study evaluates low dose radiotherapy in combination with docetaxel and cetuximab in patients with recurrent, unresectable squamous cell carcinoma of the head and neck initially treated with definitive chemo-radiation therapy.

H. Jack West, MD, Swedish Cancer Institute
H. Omer Ikizler, MD
Latest Article

PrimeMD, a Pain Reporting Smartphone Application for Patients Undergoing Head and Neck Radiation

A feasibility study of a smartphone application that patients undergoing radiation therapy for head and neck cancer can use to regularly report mucositis symptoms.

Hanmath J Neboori, MD
Latest Article

Radiation for Chemo-Sensitization: A Phase II Trial of Cetuximab and Docetaxel With Low-Dose Fractionated Radiation for Recurrent Unresectable Locally Advanced Head and Neck Carcinoma

This study evaluates low dose radiotherapy in combination with docetaxel and cetuximab in patients with recurrent, unresectable squamous cell carcinoma of the head and neck initially treated with definitive chemo-radiation therapy.

Hannah Kent-Ritchie, PhD
Latest Article

Experts Give Advice on How to Plan a Successful Lung Cancer Screening Program

Screening high-risk individuals for lung cancer with low-dose tomography is an effective and recommended approach for reducing mortality from the condition. That said, planning a lung cancer screening program can be challenging, as a successful program requires strategic multidisciplinary.

Hannah Slater
Latest Article

Paving the Way to Modern Cancer Therapy

When George P. Canellos, MD, first joined the field of oncology in the 1960s, many of his peers thought he was making huge mistake.

Harold J. Burstein, MD, PhD, Dana-Farber
Harold J. Burstein, MD, PhD, Dana-Farber&nbsp
Harold J. Burstein, MD, PhD, Dana-FarberÂ
Harold J. Burstein, MD, PhD, Harvard Medical School
Harry Erba, MD, PhD, Duke University
Harry Erba, MD, PhD, University of Alabama
Harry Erba, MD, PhD, University of Alabama at Birmingham
Harry P. Erba, MD, PhD, Duke University
Harry P. Erba, MD, PhD, UAB
Harry P. Erba, MD, PhD, University of Alabama
Harvard Medical School
Hatem Soliman, MD, H. Lee Moffitt Cancer Center & Research Institute
Haydia Haniff
Latest Article

Patients Coping With Insomnia May Benefit from Behavioral Interventions

Cognitive behavioral therapy for insomnia (CBT-I) and mindfulness-based stress reduction (MBSR) can improve sleep for patients with cancer, but CBT-I continues to be the best nonpharmacologic option

Hayley Virgil, OncLive
Hayley Virgil

Senior Editor, OncLive®
Hayley Virgil heads OncLive's feature article efforts and specializes in social issues and equality in oncology. Prior to joining the company in early 2020, she worked as an editor in numerous industries, including media, marketing, hospitality, and computer science, and freelanced in subjects such as history, culture, and the natural sciences.

Latest Article

Olaparib Plus Abiraterone/Prednisone Displays Efficacy in mCRPC

Frontline treatment with olaparib plus abiraterone/prednisone led to a PFS benefit vs olaparib or abiraterone/prednisone alone in BRCA1/2– or ATM–altered mCRPC.

Heather A
Heather A. Wa
Heather A. Wakel
Heather A. Zierhut, PhD, MS, CGC
Latest Article

New Law Widens Access to Genetic Counseling but Licensure and Coverage Barriers Persist

Telehealth, a universal term for the use of digital information and communication technologies to remotely access healthcare services, is improving availability of healthcare services, particularly for patients in rural areas.

Heather L. McArthur, MD, MPH, Cedars-Sinai Medical Center